Scott Gottlieb agarra puerta... "giratoria" a Pfizer

Former Food and Drug Administration (FDA) Commissioner Scott Gottlieb, MD has joined the board of directors of Pfizer, Inc.—the world’s largest pharmaceutical company and second largest manufacturer of vaccines. Pfizer, which posted total revenues of $53.7 billion in 2018, announced Dr. Gottlieb’s election to the board on June 27, 2019.

Dr. Gottlieb, who led the FDA from May 11, 2017 to Apr. 5, 2019, has also been appointed to the Regulatory and Compliance Committee and the Science and Technology Committee of Pfizer’s board. 

Ver:

Scott Gottlieb dice adios, firma y promete...

In response to the Pfizer announcement, U.S. Senator Elizabeth Warren (D-MA) wrote a letter to Dr. Gottlieb on July 1. 
She said, 

“this kind of revolving door influence-peddling smacks of corruption, and makes the American people rightfully cynical and distrustful… ” 

and suggested that Dr. Gottlieb should 

“rectify” his “mistake and immediately resign” from his position on the board. 

She added: 
“Doing so would send a strong and necessary message to the American people about the importance of government ethics and the integrity of current and former federal officials.” 

Warren noted that, according to Pfizer, the company’s board members were paid “$142,500 in cash retainers in 2018, plus received $192,500 worth of Pfizer stock.“

Ver:

The Revolving Door Didn’t Start at Pfizer

  Prior to his appointment as FDA commissioner, Dr. Gottlieb served on the board of directors of pharmaceutical companies Tolero Pharmaceuticals, Inc. and Daiichi Sankyo Co. He also served on the investment board of GlaxoSmithKline plc (GSK), currently the fourth largest vaccine maker in the world.

Más